Aakaar Medical Technologies Limited reported a financial performance for FY26 with revenue reaching ₹66.9 crore, up from ₹61.6 crore in the previous year. The company maintained its profitability streak with a Profit After Tax (PAT) of ₹6.6 crore compared to ₹6.0 crore in FY25. EBITDA for the period was recorded at ₹10.97 crore, reflecting an EBITDA margin of 16.39%.

The company operates through comprehensive business segments focusing on aesthetics products, devices, and device consumables. Aesthetics products and device consumables constitute the majority of the revenue, contributing to a recurring business model. The gross profit for FY26 was ₹39.5 crore with a margin of 59.34%.

Financial Performance

The statement of profit and loss highlights steady growth across key metrics. Total income for FY26 stood at ₹67.7 crore. Employee benefits expense increased to ₹14.0 crore, and other expenses were recorded at ₹14.5 crore. Finance costs for the year amounted to ₹1.6 crore.

Balance Sheet Overview

The balance sheet size expanded to ₹79.4 crore in FY26 from ₹54.2 crore in FY25. Shareholders' funds saw significant growth, with share capital rising to ₹14.2 crore and reserves and surplus reaching ₹40.3 crore. Trade receivables increased to ₹37.22 crore, while the cash and bank balance grew substantially to ₹16.2 crore.

Business Segments and Growth

Aakaar Medical Technologies offers a diversified portfolio including injectables, contouring, professional skincare, and homecare solutions. The company manages 146 brands and serves over 5,000 doctors through its distribution network. The strategy emphasizes a product-led, recurring annuity-based business model with a focus on expanding its stockist network.

Aakaar Medical Technologies Limited will hold its 13th Annual General Meeting on Tuesday, June 30, 2026, at 3:00 P.M. IST through video conference and other audio visual means. The meeting will be held to transact business as set out in the notice, complying with the Companies Act, 2013 and SEBI (LODR) Regulations, 2015. The company has completed the dispatch of the notice and the annual report for the financial year 2025-26 to shareholders whose email IDs were registered as of May 29, 2026. For members without registered email addresses, a physical letter containing the web-link to the reports was posted on June 5, 2026.

E-voting and Eligibility

The company has provided a remote e-voting facility through its Registrar and Share Transfer Agent, Bishare Services Pvt. Ltd. The remote e-voting period will commence on June 29, 2026, at 9:00 A.M. and conclude on the same day at 5:00 P.M. The cut-off date for determining eligibility for remote e-voting and voting during the AGM is June 23, 2026.

Members attending the AGM via video conference who have not cast their vote remotely may do so until 5:00 P.M. on June 30, 2026. Shareholders who have already voted remotely will not be entitled to vote again during the meeting.

Key AGM Dates

Shareholders with queries regarding e-voting may refer to the FAQs on the Bishare Services website or contact the company secretary at Aakaar Medical Technologies Limited.